Dolomite Bio announces re brand to Do Bio

February 8, 2023

Do Bios Nadia product familyDolomite Bio launches new website, with exciting re brand, a new name and focus. The motivation behind the company’s name change to Do Bio reflects their evolution within the microfluidic, biology and life science space.

The expertise behind Do bio’s technology is built on a strong foundation in the field of microfluidics. As the company has grown in recent years, the focus has shifted from purely single cell based applications, to developing and supporting multiple microfluidics based products for life sciences and pharmaceuticals.

The core value behind Do Bio’s products has always been centred on the ability to process, develop, and make biological discoveries, using the advantages of a microfluidic platform, without the complexities and high levels of expertise associated with most platforms on the market. The company refresh and name change reflects this ability to ‘do more’ with the Nadia Product family. A platform which allows researchers to process a wide variety of biologicals, from cells, to proteins, to mRNA and lipids. Whether using droplets, particles, or homogenous fluids, researchers can ‘do you’: developing novel microfluidic methodologies without compromising on reproducibility and scalability.

Following the re-launch as Do Bio, the company expects to keep expanding their product family, reagent kits and microfluidic chips and cartridges, in line with the renewed focus on empowering researchers to ‘do now’ without limitations.

About Do Bio

As part of the Blacktrace group, Do Bio draws on more than 20 years of experience in microfluidics technology. Do Bio creates innovative microfluidic products for processing a wide variety of biologicals from cells, to proteins, to mRNA and more.

Do Bio’s products include the Nadia product family and accompanying consumables, including reagent kits, chips, and cartridges. These products enable research in many application areas including; hydrogels, lipid nanoparticles and single cell/nuclei profiling. The platforms can also be used for opening up unlimited possibilities in the development of custom protocols and new applications, with the ability to scale for production.

Do Bio also offers the Single Cell Consultancy service, for all stages of biological workflows, including data analysis. As well as the Droplet Analyzer software, a free software for the detection and analysis of hydrogel scaffolds and aqueous droplets generated with microfludic platforms.

Do Bio is a brand of Blacktrace Holdings Ltd (est. 2001), a world leader in Productizing Science®. Its Head Office is in Royston (near Cambridge), UK with regional offices in the USA, Japan and Vietnam.

To learn more about Do Bio, please visit

Categories: Corporate, Finance & Investor, Life Science
Browse more news

Recent releases